Meticulous Research®—a leading global market research company, published a research report titled, ‘Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction) Application (Drug Discovery, Diagnostic, Research) End User (Pharmaceutical, Hospital, Academic) Offering (Instrument, Consumable, Software) – Global Forecast to 2031.’
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=1262
According to this latest publication from Meticulous Research®, the genomics market is projected to reach $70.52 billion by 2031, at a CAGR of 11.1% during the forecast period. The growth of the genomics market is driven by the rising prevalence of genetic diseases, the increasing incorporation of genomic data in clinical workflows, increasing funding and investments in genomics projects, the growing applications of genomics in the healthcare sector, rising pharmaceutical R&D expenditures, decreasing costs of sequencing, and increasing healthcare spending. However, the lack of standardized approaches in genomics and concerns over the security & privacy of genomic data restrain the growth of this market.
Moreover, the rising adoption of personalized medicines and gene therapies is expected to generate market growth opportunities. However, the shortage of skilled bioinformatics and genomics personnel and the commercialization and scaling of genomic technologies are major challenges for market stakeholders.
Key Plyears
The key players operating in the global genomics market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Eppendorf SE (Germany), Myriad Genetics, Inc. (U.S.), Revvity, Inc. (Formerly PerkinElmer, Inc.) (U.S.), and BGI Genomics Co. Ltd (China).
Genomics market: Future Outlook
The global genomics market is segmented by Offering (Systems, Consumables, Software, and Services), Technology (Polymerase Chain Reaction (PCR), Sequencing [Next Generation Sequencing (NGS) and Other Sequencing Technologies], Nucleic Acid Extraction and Purification, Microarray and Other Technologies), Application (Diagnostics, Drug Discovery & Development, Life Science Research [Cancer Research, Stem Cell Research, and Other Life Science Research], and Other Applications), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Diagnostic Laboratories, Contract Research Organizations (CROs), Academic & Research Institutes, and Other End Users) and Geography. The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.
Speak to Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=1262
Based on offering, the genomics market is segmented into systems, consumables, software, and services. In 2024, the consumables segment is expected to account for the largest share of the market. The large market share of this segment is attributed to increased demand for consumables for next-generation sequencing and a rise in genetic research. As genomic research grows, the demand for consumables is further expected to rise, driving the market’s growth.
Based on technology, the genomics market is segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and other technologies. The sequencing segment is expected to register the highest CAGR during the forecast period. The factors contributing to the segment’s highest CAGR are technological advancements in sequencing, improvements in the efficiency of sequencing processes, and the increased scalability of sequencing technologies. Moreover, key players are implementing various growth strategies, such as product launches, approvals, and acquisitions, contributing to the market’s growth. For instance, in August 2022, Bio-Rad Laboratories acquired Curiosity Diagnostics, Sp. Z. o. o. (Poland) for the development of a new generation of rapid PCR systems to market.
Based on application, the genomics market is segmented into drug discovery & development, diagnostics, life science research, and other applications. The drug discovery & development segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the high prevalence of chronic diseases such as diabetes and cancer and the increased need for discovering effective drug therapies against diseases.
Based on end user, the genomics market is segmented into pharmaceutical & biotechnology companies, hospitals & clinics, academic & research institutes, diagnostic laboratories, CROs, and other end users. In 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the use of genomics in targeted drug development, biomarker discovery, personalized medicine, and data analysis. Additionally, genomics is widely used in research activities by pharmaceutical and biotechnology companies as it helps identify new drug targets, improve patient outcomes, and develop more effective therapies. NGS and other genomic analysis technologies help biotech and pharmaceutical researchers better understand genetic variants related to several diseases.
Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. In 2024, North America is expected to hold the largest share of the global genomics market due to significant R&D investments, an advanced healthcare system, the presence of prominent market players, and a surge in the adoption of new technologies.
Quick Buy: https://www.meticulousresearch.com/Checkout/61289368
Key questions answered in the report-
• Which are the high-growth market segments in terms of offering, technology, application, end user, and country/region?
• What was the historical market for genomics across the globe?
• What are the market forecasts and estimates for the period 2024–2031?
• What are the major drivers, restraints, challenges, opportunities, and trends in the global genomics market?
• Who are the major players in the global genomics market?
• What is the competitive landscape like, and who are the market leaders in the global genomics market?
• What are the recent developments in the genomics market?
• What are the different strategies adopted by the major players in the genomics market?
• What are the geographical trends and high-growth regions/countries?
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research